Clinical Trial

Creatine Supplementation in Young Healthy Adults

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 20, 2024 (before its estimated January 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose is to compare the effects of bolus ingestion (5 grams) vs. intermittent ingestion (2 x 2.5 grams) of creatine supplementation vs. placebo for 21 days on measures of body composition (lean tissue mass-indicator of muscle mass, total body water) and muscle performance (i.e., power, strength, endurance).
Trial Details
NCT Number NCT06604793
Lead Sponsor University of Regina
Collaborators: Iovate Health Sciences International Inc
Conditions Improve Muscle Performance in Young Adults
Enrollment 42 participants
Start Date 2024-08-20
Primary Completion 2025-01-31 (estimated)
Study Completion 2025-01-31 (estimated)
Updated on ClinicalTrials.gov 2024-09-20